Holen Sie sich die Stockscreener-App
3.05
0.66%
0.02
Handel nachbörslich:
3.10
0.05
+1.64%
Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten
Forecasting Rocket Pharmaceuticals Inc. price range with options dataQuarterly Growth Report & Daily Entry Point Alerts - Newser
Rocket Pharmaceuticals: Reprioritization Key To Milestone Achievement By 2026 - Seeking Alpha
Rocket Pharmaceuticals Inc. stock trend outlook and recovery pathBull Run & Smart Allocation Stock Tips - Newser
Published on: 2025-08-14 16:12:45 - newsyoung.net
Can a trend reversal in Rocket Pharmaceuticals Inc. lead to recovery2025 Market Outlook & Safe Entry Momentum Stock Tips - Newser
Trendlines Converge — Decision Point for Rocket Pharmaceuticals Inc. Equity WarrantMarket Sentiment Review & Risk Controlled Daily Plans - 선데이타임즈
XTX Topco Ltd Cuts Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Chardan Capital Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price - Defense World
Rocket Pharmaceuticals Maintains Hold Rating Amid Clinical and Financial Uncertainties - AInvest
Rocket Pharmaceuticals Faces Investor Lawsuit Over Fatal Gene Therapy Trial – How to Join the Case - TradingView
Did You Lose Money on Rocket Pharmaceuticals, Inc. (RCKT)? Levi & Korsinsky Urges Investors to Act Before August 11, 2025 - Barchart.com
Deadline coming up on Aug. 11th in Lawsuit for Investors who lost - openPR.com
DEADLINE ALERT for RCKT, DDD, TEM, RDDT: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals - Business Wire
Rocket Pharmaceuticals Class Action Filed, Deadline August 11, 2025. - AInvest
DEADLINE ALERT for RCKT, TEM, and DDD: The Law Offices of - GlobeNewswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT)August 11, 2025 Deadline to JoinContact The Gross Law Firm - PR Newswire
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025RCKT - PR Newswire
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
RCKT Deadline: RCKT Investors with Losses in Excess of $100K Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit - MarketScreener
Rocket Pharmaceuticals, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before August 11, 2025 to Discuss Your RightsRCKT - PR Newswire
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Rocket Pharmaceuticals sued for securities fraud, lead plaintiff deadline Aug. 11. - AInvest
RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rocket Pharmaceuticals - Bluefield Daily Telegraph
RCKT DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
Has Rocket Pharmaceuticals Inc. Equity Warrant found a price floorFree Scalable Portfolio Growth Suggestions - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant forming a reversal patternReversal Signal Prediction Based on Volume - Newser
What high frequency data says about Rocket Pharmaceuticals Inc.Weekly Gain Forecast with Momentum Indicators - Newser
Will breakout in Rocket Pharmaceuticals Inc. lead to full recoveryProfit Target Planning with Exit Confidence - Newser
RCKT DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 11 Deadline in Securities Class ActionRCKT - ACCESS Newswire
Rocket Pharmaceuticals Hit with Class Action Lawsuit Over Securities Fraud - AInvest
Rocket Pharmaceuticals and the Rocketing Risks in Biotech Innovation - AInvest
Faruqi & Faruqi Investigates Rocket Pharmaceuticals Securities Litigation - AInvest
Combining machine learning predictions for Rocket Pharmaceuticals Inc. Equity Warrant2-Day Signal Watch with Forecast Outcome - Newser
Should you wait for a breakout in Rocket Pharmaceuticals Inc.Profitable Trading Blueprint with Entry Zones - Newser
Custom watchlist performance reports with Rocket Pharmaceuticals Inc.Free Exit Ready Momentum Stock Watchlist - Newser
Rocket Pharmaceuticals Inc. Equity Warrant stock momentum explainedBreakout Watcher with Entry and Exit Alerts - Newser
Volume spikes in Rocket Pharmaceuticals Inc. stock – what they meanSafe Entry Screening with Data Backed Analysis - Newser
Class Action Lawsuit Filed: Rocket Pharmaceuticals, Inc. (RCKT)Join by August 11, 2025Contact Levi & Korsinsky - Stockhouse
Class Action Filed Against Rocket Pharmaceuticals, Inc. - GlobeNewswire
Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Seeking Recovery for Investors – Contact Levi & Korsinsky - Morningstar
Rocket Pharmaceuticals and the Biotech Litigation Landscape: Navigating Risks in a High-Stakes Sector - AInvest
August 11, 2025 Deadline: Join Class Action Lawsuit Against Rocket Pharmaceuticals, Inc. (RCKT)Contact Levi & Korsinsky - Barchart.com
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class - GlobeNewswire
Rocket Pharmaceuticals stock price target raised to $3.00 from $2.50 at Jefferies - Investing.com Canada
Rocket Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
2025-08-07 | Securities Class Action Lawsuit Filed Against Rocket Pharmaceuticals, Inc. (RCKT)Levi & Korsinsky Represents Shareholders | NDAQ:RCKT | Press Release - Stockhouse
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd - GlobeNewswire
Rocket Pharmaceuticals Announces Strategic Restructuring and Leadership Changes - TipRanks
Investors in Rocket Pharmaceuticals, Inc. Should Contact - GlobeNewswire
Rocket Pharmaceuticals, Inc. Investors: Please contact the - GlobeNewswire
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress | RCKT Stock News - GuruFocus
Rocket (RCKT) Q2 Loss Narrows 16% - Nasdaq
Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress - Business Wire
RCKT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, - GlobeNewswire
Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) - GlobeNewswire
Lost Money on Rocket Pharmaceuticals, Inc.(RCKT)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Morningstar
Rocket Pharmaceuticals: Q2 Earnings Snapshot - New Haven Register
Tools to monitor Rocket Pharmaceuticals Inc. Equity Warrant recovery probabilityLow Drawdown Picks with Weekly Updates - Newser
2025-08-06 | Lost Money on Rocket Pharmaceuticals, Inc. (RCKT)? Contact Levi & Korsinsky Before August 11, 2025 to Join Class Action | NDAQ:RCKT | Press Release - Stockhouse
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):